Get started
RocketTickers

Motif Bio Announces FDA Acceptance of New Drug Application with

Long
RocketTickers  
NASDAQ:MTFB   None
Beyond Technical Analysis
2
0
beyondta
MTFB: Motif Bio plc
2018-08-14 02:00:00
Motif Bio Announces FDA Acceptance of New Drug Application with Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.